Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)

Triple negative breast cancer (TNBC) progresses rapidly but lacks effective targeted therapies. Our previous study showed that downregulating syndecan-binding protein (SDCBP) in TNBC inhibits the proliferation of TNBC cells. Dasatinib is a new small-molecule inhibitor of c-src phosphorylation. The a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: Qian, Xiao-Long, Zhang, Jun, Li, Pei-Ze, Lang, Rong-Gang, Li, Wei-Dong, Sun, Hui, Liu, Fang-Fang, Guo, Xiao-Jing, Gu, Feng, Fu, Li
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5283743/
https://ncbi.nlm.nih.gov/pubmed/28141839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0171169
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы